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ABSTRACT
Exposure to ultraviolet light induces a number of
forms of damage in DNA, of which (6–4) photopro-
ducts present the most formidable challenge to DNA
replication. No single DNA polymerase has been
shown to bypass these lesions efficiently in vitro
suggesting that the coordinate use of a number of
different enzymes is required in vivo. To further
understand the mechanisms and control of lesion
bypass in vivo, we have devised a plasmid-based
system to study the replication of site-specific
T–T(6–4) photoproducts in chicken DT40 cells. We
show that DNA polymerase f is absolutely required
for translesion synthesis (TLS) of this lesion, while
loss of DNA polymerase g has no detectable effect.
We also show that either the polymerase-binding
domain of REV1 or ubiquitinated PCNA is required
for the recruitment of Polf as the catalytic TLS poly-
merase. Finally, we demonstrate a previously unap-
preciated role for REV1 in ensuring bypass synthesis
remains in frame with the template. Our data there-
fore suggest that REV1 not only helps to coordinate
the delivery of DNA polymerase f to a stalled primer
terminus but also restrains its activity to ensure that
nucleotides are incorporated in register with the
template strand.
INTRODUCTION
DNA damage-induced mutations arise in consequence of
the use of specialized DNA polymerases to synthesize
across base lesions that have arrested DNA replication,
a process known as translesion synthesis (TLS).
These polymerases, which are found in all organisms, pos-
sess active sites that are more tolerant of damage to, or
distortions of, the DNA template that would stall the
replicative polymerases (1,2). Although deployment of
TLS allows replication to be completed, it does so at the
cost of an increased error rate. This is not only because
most DNA lesions are non- or mis-instructional, but also
because the TLS polymerases themselves are error-prone.
Although it is likely that the use of TLS is frequently anti-
mutagenic at a given DNA lesion, the high intrinsic error
rate of many of these enzymes means that the access of the
translesion polymerases to nascent 30-termini must be
tightly regulated.
Originally identiﬁed in the budding yeast Saccharo-
myces cerevisiae, the ubiquitination of the DNA sliding
clamp PCNA (POL30) at lysine 164 by RAD6/RAD18
appears to be a conserved mechanism in eukaryotes for
recruitment of translesion polymerases (3,4). The modiﬁ-
cation is proposed to increase the aﬃnity of the clamp for
the Y-family translesion polymerases (Pols Z, i, k and
REV1) through an interaction with ubiquitin-binding
domains located within the polymerases themselves (5).
A B-family polymerase, DNA polymerase z, is also
required for eﬀective translesion synthesis. Polz comprises
two subunits, REV3, which includes the catalytic domain
and REV7, whose functions are less well understood (6).
REV7 also interacts with the extreme C-terminus of REV1
(7), a domain that additionally interacts with each of the Y
family polymerases (8). Polz is conserved from yeast to
mammals, and although vertebrate REV3 is much larger
than its yeast counterpart, the function of the additional
sequence is unclear.
Monoubiquitination of PCNA is also needed for a more
poorly understood error-free recombinational mode of
bypass in S. cerevisiae (9), thought to be a form of tem-
plate switching (10). In this context, the initial ubiquitin
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lysine 63-linked polyubiquitination by RAD5/MMS2/
UBC13 (3). Although the function of the polyubiquitin
chain is currently unclear, RAD5 has also been shown
to be a helicase capable of catalysing fork regression
in vitro (11). There is evidence that many aspects of this
mechanism are conserved in higher eukaryotes although
to date there is only relatively limited genetic data to sup-
port its importance (12–14).
In the study presented here, we employ the genetically
tractable chicken cell line DT40, which currently provides
the most versatile genetic system for studying vertebrate
DNA damage tolerance mechanisms (15). Homologues of
the S. cerevisiae RAD6 epistasis group, which comprises
genes involved in DNA damage tolerance, are present in
DT40 and are well conserved between chicken and human
(16). Ubiquitination of PCNA plays an important role in
DNA damage tolerance in DT40 (17,18), although the
role of this modiﬁcation is not as central as it is in yeast
(17–20) and RAD18 does not appear to be the sole
ubiquitin ligase responsible (18). Further, the C-terminal
region of the Y-family polymerase REV1 has acquired
greater prominence in the control of lesion bypass in
DT40 compared with yeast and is able to act indepen-
dently of PCNA ubiquitination in coordinating transle-
sion synthesis (19).
A particularly powerful method for studying DNA
damage tolerance is to monitor the outcome of the repli-
cation of a deﬁned lesion at a known site in shuttle plas-
mids. Of the many approaches taken to this problem, we
were drawn to an experimental arrangement devised by
Lawrence and colleagues that seemed well suited for adap-
tation to use in a vertebrate cell system. The system com-
prises a plasmid capable of episomal replication in which a
thymine–thymine pyrimidine (6–4) pyrimidone photopro-
duct is incorporated into each strand, staggered 28-bp
apart. Each photoproduct is placed opposite a C–C mis-
match (21,22). This arrangement allows the unbiased
detection, in recovered replicated copies, of TLS on
either strand or error-free bypass.
Although produced in UV-irradiated DNA at only
about a third of the frequency of the cyclobutane pyrimi-
dine dimer, the (6–4) photoproduct presents a much more
potent block to replication (23) by introducing very sig-
niﬁcant distortion into the DNA backbone with the 30
base orientated almost perpendicular to the 50 base
(24,25). Indeed, in vitro, no single polymerase is able to
eﬃciently bypass this lesion leading to the proposal that,
in vivo, bypass is a two-step process with one polymerase
incorporating opposite the 30T and a second performing
the second incorporation and extension (26).
To allow direct comparison with the work of Zhang and
Lawrence, we have devised a plasmid capable of replicat-
ing in DT40 into which we incorporate a pyrimidine–
pyrimidone T–T(6–4) photoproduct as a model DNA
replication-stalling lesion. Using this system, we ﬁnd that
TLS is used some ten times more frequently in DT40 than
has been reported for S. cerevisiae (22). Interestingly, loss
of PCNA ubiquitination does not aﬀect the ability of the
cells to perform error-free bypass, but does play a role in
recruitment of DNA polymerase z, which is essential for
TLS of this lesion, despite no known direct interaction
between ubiquitin and Polz. Further, we show that
REV1 not only acts in parallel with PCNA ubiquitination
to facilitate Polz-dependent bypass, but that it also modi-
ﬁes the catalytic behaviour of Polz, restraining its syn-
thetic activity to ensure the frame of bypass is maintained.
MATERIALS AND METHODS
Plasmid construction
The pQ1 plasmid was constructed from two halves. First,
pentameric Gal4 sites provided by the oligonucleotides
50-CGCGA(CGGAGGACAGTACTCCGCT)5A and
50-CGCGT(AGCGGAGTACTGTCCTCCG)5T were
ligated into an MluI site created in pIRES2-EGFP
(Clontech, St. Germain-en-Laye, France) by site-directed
mutagenesis using the primers 50-CAATGTATCTTAAC
GCGTAAATTGTAAG and 50-CTTACAATTTACGCG
TTAAGATACATTG. This ligation preserved an MluI
site downstream of the insertion. After ﬁlling in the only
MfeI site and religation, the Kan
R region was removed
from the plasmid using MluI and NsiI. The replacement
Amp
R gene was provided by a pBluescript plasmid
(Stratagene, Amsterdam, The Netherlands) which had a
polylinker inserted into the blunt PsiI site using the oligo-
nucleotides 50-GAATTCGGTACCCATATGCTGCAG
and 50-CTGCAGCATATGGGTACCGAATTC to allow
for the cloning of lesion-containing oligonucleotides into
the ﬁnished pQ1. A region of the modiﬁed pBluescript was
ampliﬁed using the primers 50-GGTACGCGTCGCGC
CCTGTAGCGGCGC (containing an MluI site) and 50-
GCACCACTGCAGTGGGAACATGTGAGCAAAAG
GCC (containing a PstI site ﬂanked by two halves of a
BstXI site) and cut with MluI and BstXI (which mimics
a PstI cut in the primer). The cut PCR product was ligated
into the MluI and NsiI cut modiﬁed pIRES2-EGFP, giving
pQ1CDC6. One EcoRI site and two PstI sites were
removed silently from human CDC6 by site-directed muta-
genesis, and the product was ampliﬁed using primers
50-GAGTCGACCATGCCTCAAACCCGATCCCAG
and 50-GAGGATCCTTAAGGCAATCCAGTAGCTAA
G containing SalI and BamHI sites. The DNA-binding
domain of GAL4 was cut out of pDBLeu (Stratagene)
using HindIII and SalI. The GAL4DBD-hCDC6 fusion
was assembled in pBluescript (Stratagene) containing a
modiﬁed polylinker (NheI–HindIII–SalI–BamHI), and
subcloned into pQ1CDC6 using NheI and BamHI.
The kanamycin-resistant pQ2 control plasmid was
based on pQ1. A SacI site was created in pQ1 between
the Amp
R cassette and the pUC origin by site-directed
mutagenesis using the primers 50-CCCTTAACGTGAG
AGCTCGTTCCACTGAGCG and 50-CGCTCAGTG
GAACGAGCTCTCACGTTAAGGG. The Amp
R cas-
sette was removed using PstI and SacI, and replaced
with the Kan
R cassette ampliﬁed from pCR2.1-TOPO
using the primers 50-CACTGCAGGGCGCAAGGG
CTGCTAAAGG and 50-CAGAGCTCAGAAGAACT
CGTCAAGAAGG containing sites for PstI and SacI,
respectively.
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were synthesized using a previously described building
block (27). The following oligonucleotides were used:
TTF1 (AATTGTCCACCTC-T(6–4)T-CCTGTATTCT
TAGTACCTACTGACGCTAGCTCGATCCATGCA),
TTR1 (TGGATCGA-T(6–4)T-TAGCGTCAGTAGGTA
CTAAGAATACAGGGCGAGGTGGAC), TTR2 (TGG
ATCGAGCTAGCGTCAGTAGGTACTAAGAATAC
AGG-T(6–4)T-GAGGTGGAC). In the lesion-free con-
trol oligonucleotides, TTFC and TTRC, the photopro-
ducts were replaced by the dinucleotide GC. The inserts
for the lesion-containing constructs were annealed pairs
of oligonucleotides as follows: QTs (TTF1 and TTR1),
QTo (TTF1 and TTR2), QTc (TTFC and TTRC). The
annealed inserts were ligated into pQ1 in two steps as
described (22). The ﬁnal ligation mix was found to contain
over 75% circular product, and was used for transfection
without a gel puriﬁcation step.
Cell cultureand transfection
DT40 cells were grown at 378C in RPMI medium supple-
mented with 7% fetal bovine serum and 3% chicken
serum. The DT40 lines null for polh, rev3, rad18 and rev1
and the pcnaK164R and rev1 pcnaK164R mutants have
been described previously (17,28–31). Selection cassettes
were excised from the rev1 and pcnaK164 lines, together
with the AID transgene these lines contain, by the addition
of 50nM 5-hydroxytamoxifen to the media for Cre induc-
tion. A puromycin resistant XPA knockout construct (32)
was used to disrupt the single xpa allele and recreate
the xpa cell line as well as generate double mutants.
The hREV1 reconstitutions have been described (19,20).
Colony survival assay on methylcellulose-containing
medium was performed as previously described (29). All
transient transfections were performed using an Amaxa
nucleofector device (Amaxa, Cologne, Germany) with
reagent T according to the manufacturer’s instructions.
Three million DT40 cells were transfected and immediately
recovered into 5ml warm medium. The amount of plasmid
transfected was optimized so as to produce <10% EGFP-
positive cells to limit the number of cells expected to take
up more than one copy of the plasmid. For transfections
with ligated shuttle plasmid, the ligation product of 1mg
pQ1 was used (containing  0.1mg ligated circular plas-
mid), supplemented with 0.4mg pQ2 in experiments used
for the measurement of plasmid replication eﬃciency.
EGFP expression from the plasmid was analysed at var-
ious time points after transfection using a Becton–
Dickinson FacsCalibur ﬂow cytometer.
Plasmid extraction and bacterial transformation
Cells transfected with lesion-containing plasmids were cul-
tured for 48h before plasmids were extracted using a sim-
pliﬁed Hirt protocol. PBS washed cells were resuspended
in buﬀer P1 from a Qiagen plasmid miniprep kit (Qiagen,
Crawley, UK), followed by a 5-min lysis in buﬀer P2 and
neutralization in N3. Plasmid DNA was recovered from
the supernatant of a high-speed spin by the addition of
glycogen and isopropanol precipitation. Dried pellets were
dissolved in 10ml enzyme digest mix containing 10U DpnI
and incubated for 30min. DNA was once more recovered
by isopropanol/ethanol precipitation, dissolved in water
and used to transform DH10B electrocompetent cells
(Invitrogen, Paisley, UK) using a Bio-Rad Gene Pulser
(Bio-Rad, Hemel Hempstead, UK) at 200, 0.25mF and
1.8kV. In experiments assaying plasmid replication eﬃ-
ciency, 80% of transfections were plated on ampicillin
plates and 20% on kanamycin-containing medium.
RESULTS
Areplicating plasmid inDT40 cells
To exploit the powerful genetics aﬀorded by DT40 for
monitoring lesion bypass in replicating plasmids, we ﬁrst
set out to identify a plasmid that replicated reliably in this
cell line. We initially explored the use of pEPI-1 (33), a gift
of Professor Hans Lipps. This plasmid expresses GFP
from a CMV promoter and contains a human matrix
attachment region. In human cells, this leads to the chro-
matinization of the plasmid and its replication and stable
maintenance during prolonged culture. In DT40, however,
pEPI was subject to aggressive degradation following
transfection and was poorly maintained (data not
shown). Copies of the plasmid that have been replicated
in DT40 become resistant to cleavage by the restriction
enzyme DpnI due to loss of Dam methylation. Although
some replication of pEPI did take place, as assessed by the
recovery of DpnI-resistant copies of the plasmid from Hirt
supernatants, the frequency with which such copies were
recovered was very low.
We therefore constructed a plasmid, pQ1, based on the
observation that tethering CDC6 to DNA is suﬃcient to
create an origin of replication in human cells (34). pQ1
consists of a CMV promoter-driven human CDC6 fused
with an N-terminal GAL4 DNA-binding domain. An
internal ribosomal entry signal drives expression of
enhanced green ﬂuorescent protein. Five repeats of the
GAL4 recognition sequence are placed in an A:T base
pair rich region of the plasmid 200-bp upstream of a clon-
ing site into which the lesion-containing oligonucleotide is
ligated (Figure 1A).
To assess the replication and maintenance of this plas-
mid following transient transfection, wild-type DT40 cells
were transfected with 5mg pQ1 or pQ1CDC6, a variant
of pQ1 lacking the HsCDC6 open reading frame. The
percentage of GFP positive cells was monitored by ﬂow
cytometry at 24h (the earliest point at which strong GFP
expression could be detected) and then at 24h intervals
thereafter. In the absence of CDC6, the percentage of
GFP positive cells declined steadily over four days after
transfection. However, with GAL4-HsCDC6 present, the
percentage of GFP positive cells increased for 2 days
before the plasmid began to be lost from the population
(Figure 1B). The decay in GFP expression in both cases
was accompanied by extensive degradation of the plasmid
as assessed by Southern blot (data not shown). Although
replication of pQ1 is tempered by competing nucleolytic
degradation, DpnI-resistant plasmid was readily recov-
ered 48h following transfection providing further evidence
that pQ1 is replicated.
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toassess translesion synthesis and error-free bypass
T–T(6–4) photoproduct-containing oligonucleotides were
synthesized as previously described (27) and were ligated
into pQ1 using the two-step technique described by the
Lawrence laboratory (21,22) so as to maximize the
amount of covalently closed plasmid (see also Materials
and methods section). A separate photoproduct placed on
each strand of DNA makes damage bypass necessary for
any replicated plasmid product. The photoproducts were
arranged in one of two ways. In the staggered conforma-
tion (pQTs), the lesions are separated by 28 intervening
base pairs and placed opposite a GpC mismatch.
Replicated copies can thus result from TLS on the top
strand or bottom strand. Error-free bypass or excision
repair of the lesions is reported by the presence of GpC
at the site of the dimer (Figure 1C). Although GpC could
be inserted by TLS, evidence available to date suggests
that this combination of base insertions opposite a
T–T(6–4) photoproducts would be unusual (35). We also
created an unphysiological substrate in which the lesions
are placed opposite each other (pQTo). This arrangement
can only lead to replicated copies by TLS, or by deletion
(Figure 1D). The eﬀectiveness of the block to DNA
Figure 1. A system for monitoring lesion bypass in a replicating plasmid. (A) Layout of the pQ1 shuttle plasmid. pUC ori, pUC bacterial replication
origin; CMV prom, cytomegalovirus promoter; Gal4-DBD, GAL4 DNA-binding domain; hCdc6, human CDC6 coding sequence; IRES, internal
ribosome entry sequence; EGFP, enhanced green ﬂuorescent protein; 5 Gal4 sites, pentameric Gal4 binding sites. (B) A daily time course of the
percentage of wild-type DT40 cells expressing GFP after transfection with 5mg of pQ1 or a variant lacking the human CDC6 reading frame
(pQ1CDC6). Error bars represent 1 SD. (C) A schematic of the staggered arrangement of T–T(6–4) photoproducts in the construct pQTs, with
the dinucleotide GC placed opposite each lesion, and 28bp between the lesion with the possible outcomes of DNA replication over the area. TLS
may occur on either the top or the bottom strand, with the most common base insertion shown as (AA). Alternatively, the nascent strand of the
sister chromatid may be used as an alternative undamaged template; one possible layout for such a template switching mechanism is illustrated.
(D) A schematic representation of the opposing arrangement of T–T(6–4) photoproducts in the construct pQTo and the possible outcomes of DNA
replication, only by TLS, over the lesion. (E) Part of a DNA sequencing reaction of the pQTo construct is shown to illustrate the purity of the
preparation. The sequencing polymerase stalls at the lesion, and inserts an adenosine opposite the 30T.
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and the purity of the preparations is illustrated by DNA
sequencing (Figure 1E). Note that the sequencing poly-
merase inserts an A opposite the 30T of the photoproduct
before further extension is blocked.
Efficiency of replication of pQ1harbouring T–T(6–4)
photoproducts inwild-type and nucleotide excision
repair-defective DT40 cells
We next assessed the eﬃciency with which DT40 is able to
replicate pQTs and pQTo. To do this, we cotransfected
ﬁxed amounts of a kanamycin-resistant version of
pQ1 (called pQ2) with the lesion-containing pQ1-derived
ampicillin-resistant constructs. Following plating of the
recovered plasmid separately on both ampicillin and
kanamycin-containing plates we normalized the number
of Amp
R colonies to the internal Kan
R control. In com-
parison to a plasmid containing a ligated lesion-free oligo
(pQTc), wild-type cells were able to replicate both pQTs
and pQTo with 50% eﬃciency (Figure 2A). As T–T(6–4)
photoproducts are excellent substrates for nucleotide exci-
sion repair, the eﬃciency of replication might be expected
to be signiﬁcantly enhanced by repair of the lesion before
replication. We therefore performed the same experiments
in cells in which the XPA locus was disrupted (32).
Disruption of XPA renders DT40 signiﬁcantly sensitive
to UV light (Figure 2B) but surprisingly had little eﬀect
on the replication eﬃciency of pQTs (Figure 2A) suggest-
ing that the plasmid can replicate eﬃciently with the lesion
in place. There was a greater impact of XPA disruption on
the eﬃciency of replication of pQTo consistent with this
being a more diﬃcult replication substrate for which there
is no option to perform error-free bypass.
DT40cells makeextensive useof translesion synthesis in
bypassingT–T(6–4) photoproducts, which inthe majority
ofcases is accurate
To assess the mode of bypass used in producing replicated
copies of pQTs we sequenced the plasmids recovered from
wild-type and xpa DT40 and subjected to DpnI digestion.
Figure 2. Lesion bypass in wild-type and xpa cells. (A) Eﬃciency of replication of shuttle plasmids transfected into WT and xpa cells, and recovered 48h
later. A ligated lesion-free control preparation pQTc as well as two diﬀerent lesion-containing constructs, pQTs and pQTo were used. These Amp
R
constructs were co-transfected with the Kan
RpQT2 plasmid,allowing for the normalization ofthe numberof recovered replicated pQ1-derived constructs
against the internal pQ2 control. The average and SEM of 3–5 experiments is shown. (B) Colony survival assay measures the UV light sensitivity of wild-
type (WT) and xpa mutant cell lines. Diamonds, WT; squares, xpa. Error bars represent 1 SD. For clarity, only positive error is shown. (C) Example
sequences of replicated pQTs plasmids recovered from xpa cells are shown, aligned with a schematic drawing of pQTs. The sequences are sorted,
demonstrating TLS on the top strand (inserting mostly AA in the reverse direction, top set), TLS on the bottom strand (middle set), and error-free
bypass (bottom set). The proportions are not representative. (D) The proportion of TLS versus error-free bypass in pQTs sequences recovered from wt or
xpa cells, shown as percentage of the total. A total of over 80 sequences are shown as a sum of three or more independent experiments.
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the top strand and bottom strand. We also found in both
wild-type and xpa cells abundant error-free processing,
as evidenced by GpC bases at the site of the dimer
(Figure 2C). Since these products are found in copies of
the plasmid that had replicated in DT40 cells in the
absence of nucleotide excision repair we believe that they
reﬂect ‘error-free’ recombinational bypass of the
photoproduct.
In wild-type cells, TLS was used in 27% of cases. This
increased to 47% in xpa cells (Figure 2D and Table 1). By
comparison, a similar construct was replicated using TLS
in only 4% of cases when introduced into excision repair-
defective S. cerevisiae (22). The pattern of TLS was very
similar in WT and xpa cells (Figures 2C and 5; see also
Supplementary Table S1 for raw ﬁgures for all TLS spec-
trum data). In over 50% of cases, TLS was accurate with
ApA being inserted opposite the T–T photoproduct. Two
common misinsertions could be observed: a T instead of A
opposite the 30 T of the lesion, and an A instead of the
correct base at the 50+1 position, i.e. at the ﬁrst inserted
base after the lesion is bypassed. We also observed infre-
quent insertion of other bases or deletion of two or more
bases at the site of the lesion (Figures 2C and 5). Although
our staggered lesion reporter system cannot distinguish
TLS incorporating GpC from error-free bypass, the
more commonly expected GpA is not frequently seen.
We also classiﬁed the outcomes of bypass in sequences
obtained from the QTo construct, in which bypass can
be eﬀected only by TLS or deletion. Because two lesions
are opposite each other, there is no a priori information on
the direction of TLS in replicated sequences. However,
after the analysis of TLS outcomes from pQTs, we
found that we can predict the direction of TLS in pQTo
from the resulting sequence in 98% of cases (for example,
the insertion of AA is very much more common than TT).
This allowed us to draw up the spectrum of base insertions
in the pQTo construct as well. It is very similar to
that seen for pQTs (Figure 5) and conﬁrms that GpC
is only extremely rarely seen in bypass of T–T(6–4)
photoproducts.
In addition, occasional base substitutions were seen in
other regions of the oligonucleotide insert but these were
at low frequency, exhibited no clear genetic dependence
and will not be considered further here.
DNA polymerasef is absolutely requiredfor bypass ofa
6–4PP by translesion synthesis
We next examined the requirement for DNA polymerases
z and Z for TLS of the T–T(6–4) photoproducts. Both
polymerases have been implicated in a two-step model
for bypass of this lesion (36). Again to eliminate interfer-
ence from nucleotide excision repair, we disrupted the
XPA locus in both rev3 and polh DT40 lines (28,30). Dis-
ruption of REV3, the catalytic subunit of Polz, did not
result in a signiﬁcant decrease in overall replication eﬃ-
ciency of pQTs (Figure 3A). However, analysis of the
pattern of bypass revealed an almost complete absence
of TLS in xpa rev3 cells, with only one out of 133
sequences (0.8%) showing evidence of error-prone
bypass, and this was a two base deletion (Figure 3C and
D, Table 1). All other sequences were the result of error-
free bypass. In agreement with this, the replication of
pQTo, in which no donor exists for error-free bypass, is
severely compromised in xpa rev3 cells (Figure 3B).
Sequence from the recovered replicated plasmids revealed
an almost complete absence of TLS (Figure 3C). Instead,
we observed the deletion of two or more bases covering
the site of the lesion, suggesting ineﬃcient lesion bypass by
template misalignment in the absence of REV3
(Figure 3E). Xpa polh cells exhibited unexplained but
reproducibly poorer survival following transfection than
the other lines tested here and suﬃcient replication eﬃ-
ciency data were only obtained with the pQTs plasmid.
These data showed that xpa polh cells are able to replicate
pQTs with similar eﬃciency to wild type (Figure 3A) and
that the spectrum of TLS in this line is essentially identical
to that in WT and xpa cells (Figure 5). In particular, there
was no change in the low frequency with which G was
incorporated opposite the 30T of the lesion. Together,
these data do not support PolZ playing a signiﬁcant role
in the bypass of (6–4) photoproducts in this system. How-
ever, they demonstrate the critical importance of Polz.
PCNA ubiquitination and theC-terminal region ofREV1
play complementaryroles in coordinating [6–4]
photoproduct bypass
Although the ubiquitination of PCNA is absolutely cen-
tral to DNA damage bypass in yeast, recent work has
demonstrated that, in DT40, the C-terminus of REV1
can also coordinate lesion bypass independently of
PCNA ubiquitination (19,20). We have proposed that
these two pathways of TLS coordination deﬁne tempo-
rally separate modes of bypass, with REV1 acting at
stalled replication forks and PCNA ubiquitination at
post-replicative gaps (19). The experimental protocol
described here allowed us to directly examine the
Table 1. Type of bypass in recovered pQTs plasmids
TLS TLS (%) Error-free Error-free
(%)
Total No.
expts.
WT 27 27.0 73 73.0 100 3
xpa 70 46.7 80 53.3 150 3
xpa rev3 1 0.8 132 99.2 133 3
xpa polh 64 54.2 54 45.8 118 5
xpa rev1 42 27.5 111 72.5 153 5
xpa rad18 65 53.7 56 46.3 121 3
xpa pcnaK164R 27 31.4 59 68.6 86 5
rev1 pcnaK164R 3 3.3 88 96.7 91 3
rev1:hREV1 14 36.8 24 63.2 38 4
rev1:hREV1cat 31 44.3 39 55.7 70 3
rev1:hREV1C 7 6.7 97 93.3 104 3
Escherichia coli 2 5.0 38 95.0 40 2
The number of sequences generated by TLS and by error-free bypass is
shown, followed by the percentage in each group. The total number of
sequences analysed is presented in the column ‘Total’ and the number
of independent experiments performed to generate each database
shown in ‘No. expts.’. The spectrum of bypass obtained following
introduction of the plasmid directly into E. coli is also shown.
hREV1cat = hREV1
[D570A/E571A]; hREV1C = hREV1
[1–1137].
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to TLS at a deﬁned DNA lesion.
Disruption of PCNA ubiquitination either by mutation
of RAD18 or the target lysine at position 164 in PCNA in
xpa cells did not aﬀect the overall eﬃciency of replication
of pQTs or of pQTo (Figure 4A). Examination of the
pattern of bypass, however, revealed a modest decrease
in the frequency with which TLS was used in the
pcnaK164R mutant cells, but not in the rad18 cells
(Figure 4C). This diﬀerence is likely to be explained by
the existence of RAD18-independent ubiquitination of
PCNA in DT40 cells (18). Perhaps more surprising is
the robust error-free bypass in cells lacking PCNA ubiqui-
tination. This suggests that loss of post-replicative TLS
can be readily compensated for by error-free modes of
gap ﬁlling. Further, it suggests that either error-free
bypass by template switching can take place eﬃciently
without PCNA ubiquitination or that classical homolo-
gous recombination can very eﬃciently substitute for the
loss of PCNA ubiquitination-dependent error-free bypass.
The xpa rev1 cells, in contrast, do show a decrease in the
eﬃciency with which they can replicate both pQTs and
pQTo, when compared to xpa cells [P=0.039 and
0.009, respectively (unpaired t-test); Figure 4A]. We also
observed a decrease in the use of TLS within replicated
copies of pQTs from 47% to 27% following disruption of
REV1 (Figure 4C, Table 1). Further, the proportion of
accurate TLS (i.e. incorporation of ApA) decreased
from 54% in xpa cells to 30% in xpa rev1 cells. This
suggests that a proportion of REV1-dependent bypass
events cannot be substituted by error-free bypass, but
that as previously proposed, REV1-dependent TLS plays
a substantially non-overlapping role to TLS dependent on
PCNA ubiquitination in DT40 (19,20). Importantly,
neither loss of REV1 nor PCNA-ubiquitination signiﬁ-
cantly alter the spectrum of nucleotides inserted during
bypass in the remaining plasmids replicated by TLS
(Figure 5), suggesting that in this context both mechan-
isms are controlling the same polymerase, Polz.
To test this, we examined bypass in rev1 pcnaK164R
cells. Despite repeated attempts, we were unable to disrupt
the XPA locus in this line, probably reﬂecting the antici-
pated exquisite sensitivity such a line would exhibit to
many forms of DNA damage, and so we compared
its response with that of wild-type cells. While we did
not observe a reduction of pQTs replication in rev1
pcnaK164R cells, the eﬃciency of replicating the pQTo
construct was signiﬁcantly reduced (P=0.006, unpaired
t-test) (Figure 4B). The analysis of the bypass pattern is
even more revealing, as very few sequences (3/91) showed
use of TLS (Figure 4C, Table 1). Thus, the inactivation
of both REV1 and PCNA ubiquitination resulted in an
8.2-fold reduction of the use of TLS compared to the wild-
type. Although a proportion of the ‘error-free’ bypass seen
in the rev1 pcnaK164R cells may be due to excision repair,
the reduction in the use of TLS far exceeds the diﬀerence
Figure 3. REV3 is required for TLS over the T–T(6–4) photoproduct. (A) Replication eﬃciency of the pQTs shuttle plasmid in xpa, xpa rev3 and xpa
polh cells, normalized against an internal pQ2 control as in Figure 2. The average and SEM of 3–5 experiments is shown. (B) Replication eﬃciency of
the pQTo shuttle plasmid in xpa and xpa rev3 cells. (C) The proportion of TLS versus error-free bypass in pQTs sequences recovered from xpa, xpa
rev3 and xpa polh cells, shown as a percentage of the total. (D and E) Aligned example sequences from replicated pQTs (D) and pQTo (E) constructs
recovered from xpa rev3 cells.
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less than 2-fold reduction seen when each factor is dis-
rupted on its own in the xpa background (Figure 4C).
These results argue that DNA polymerase z can be
recruited to PCNA by distinct ubiquitin- and REV1-
dependent mechanisms and that in the absence of both
methods of recruitment TLS is almost completely
disabled.
REV1is requiredto ensure the maintenanceof frame
during TLSof aT–T(6–4) photoproduct
While we ﬁnd that PCNA ubiquitination and REV1 have
separate and likely non-overlapping roles in REV3 recruit-
ment, we also considered whether either mechanism aﬀects
the accuracy of TLS. An analysis of TLS events in both
pQTs and pQTo constructs concentrating on the frame
of bypass (i.e. the number of bases inserted opposite
the lesion) reveals a striking defect in xpa rev1 cells
(Figure 6A). The loss of REV1 is prominently associated
with the incorporation of a third base opposite the
T–T(6–4) photoproduct, always an A, resulting in a+1
frameshift (22% in pQTs, 39% in pQTo), although there
is also an increase in deletions (33% in pQTo) (Figure 6A
and B). This was observed in both of two independently
derived rev1 mutants (17,29). In contrast, in almost all
cases (over 95%), TLS in wild-type and xpa cells is
accomplished without any alteration in frame, in other
words gain or loss of bases relative to the template. This
is the case even when TLS involves a run of three or
more bases (Figures 2C and 6A). PCNA ubiquitination-
defective and PolZ-deﬁcient cells both exhibited compar-
able patterns to wild-type and xpa cells (Figure 6A).
Interestingly, loss of PCNA ubiquitination appears to
suppress the+1 frameshifts seen in the rev1 mutant
(Figure 6A). While this suggests that this (i.e. the frame-
maintenance) function of REV1 predominantly operates
in
UbPCNA-dependent post-replicative bypass, the abso-
lute numbers of TLS events in rev1 pcnaK164R cells is
rather low, especially for pQTs (Supplementary Table 1).
This conclusion can therefore only be drawn tentatively.
As discussed earlier, the function of REV1 in bypass of
lesions that are not its catalytic substrates depends on the
capacity of its C-terminus to bind the other TLS poly-
merases, including Polz (7,8). To ascertain whether the
maintenance of frame during bypass depends on this
C-terminal polymerase-binding domain, we examined
T–T photoproduct bypass in pQTo in rev1 cells comple-
mented with human REV1 (hREV1), an hREV1 catalytic
mutant (hREV1
[D570A/E571A]) and an hREV1 lacking the
C-terminal polymerase-binding domain (hREV1
[1–1137])
(19,20). Although these experiments were performed with-
out the disruption of the XPA locus, they revealed
Figure 4. The dual control of TLS by REV1 and PCNA ubiquitination. (A and B) Replication eﬃciency of the pQTs and pQTo shuttle plasmids in
xpa, xpa rev1, xpa rad18 and xpa pcnaK164R cells (A), and in wt and rev1 pcnaK164R cells (B), normalized against an internal pQ2 control as in
Figure 2. The average and SEM of 3–5 experiments is shown. (C) The proportion of TLS versus error-free bypass in pQTs sequences recovered from
the indicated cell lines, shown as a percentage of the total.
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[1–1137], exhibit a defect
in the eﬃciency with which pQTo was replicated
(Figure 7A) and less frequent use of TLS in pQTs
(Figure 7B and Table 1) compared with wild-type,
hREV1 and hREV1
[D570AE571A] complemented cells.
Absence of the C-terminus of REV1, but not disruption
of the catalytic domain of REV1, also revealed a substan-
tial elevation in+1 frameshifts associated with bypass of
the T–T photoproduct (Figure 7C). Together, these data
suggest that the C-terminal polymerase-binding activity
of REV1 is required to ensure accurate maintenance of
frame during bypass of a (6–4) photoproduct by DNA
polymerase z.
DISCUSSION
The nature ofthe error-freebypass in pQ-derived plasmids
These experiments reveal clear evidence for the existence
of an error-free mode of DNA damage bypass in a verte-
brate cell. The T–T(6–4) photoproduct is a very potent
replicative block. Placing two of these lesions on opposite
strands, staggered by 28bp and opposite a GC mismatch,
allows us to monitor both translesion replication and
recombinational damage avoidance. However, the T–
T(6–4) photoproduct is also an excellent target for nucleo-
tide excision repair on account of the signiﬁcant distortion
it introduces into the DNA duplex. Our experimental con-
ﬁguration is unable to distinguish between error-free
bypass and excision repair as both will result in plasmid
in which the T–T at the photoproduct appears to have
been replicated as GpC. However, the approximate 2-
fold increase in the number of sequences generated by
TLS following disruption of XPA (Figure 2D), a key
factor involved in both transcription coupled and global
genome repair (37), suggests that no more than about 50%
of the (6–4) photoproducts in the pQ plasmids are subject
to nucleotide excision repair before replication in wild-
type cells.
In terms of pathways other than nucleotide excision
repair that could trigger the excision of damage and lead
to an ‘error-free’ outcome, there is no evidence that base
excision repair can act at (6–4) photoproducts. Although
the human mismatch recognition heterodimer MSH2/6
(hMutSa) can bind (6–4)T–T photoproduct-containing
mismatches (38), more recent evidence suggests that this
binding does not stimulate excision in vitro (39). Further,
an msh2 mutant DT40 behaved no diﬀerently from wild-
type in the proportion of pQTs replicated by TLS (data
not shown).
Various assays have consistently shown that budding
yeast relies much more heavily on error-free recombina-
tional modes of bypass of DNA lesions than on TLS.
Zhang and Lawrence (22) noted that TLS was used
only 4% of the time, the remainder being error-free
and the result of either RAD5-dependent template
switching or RAD52-dependent homologous recombina-
tion. Similar ﬁgures have been arrived at by the Fuchs and
Prakash (40,41) labs, who reported TLS being used in 8%
of bypass events at an N-2-acetylaminoﬂuorene (AAF)
adduct and 6% at an abasic site, respectively, the remain-
der being the result of other error-free processes. In
the experiments we present here, the fraction of lesion
containing plasmid replicated by nucleotide excision
repair defective cells was similar to that found in yeast
Figure 5. The pattern of nucleotide incorporation opposite the T–T(6–4)
photoproduct. Data for pQTs and pQTo are shown individually. Error-
free pQTs sequences are excluded from the analysis. The percentage of
each nucleotide incorporated at each position is indicated by the size of
the letter of the nucleotide in the column; del, deletion. The incorporation
positions indicated are at the 30T and 50T of the lesion followed by the
next two bases in the template, indicated 1 and 2. Insertions before
the+1 position are indicated in the column ‘ins’, which is also indicated
by a shaded grey box. The pQTs plasmids recovered from the xpa rev3
and rev1 pcnaK164R lines had replicated almost exclusively by an error-
free mechanism and generated to few mutant sequences to be plotted,
indicated by ‘na’ (not applicable); nd, not done.
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However, the fraction generated by translesion replication
was very diﬀerent (47% versus 4% of recovered plasmids)
suggesting that DT40 relies much more heavily on TLS
than do yeast cells. This may reﬂect a greater pressure to
avoid potentially destabilizing recombination when repli-
cating a larger and more complex genome.
A further surprising observation in our DT40 experi-
ments is the lack of impact the loss of PCNA ubiquitina-
tion has on error-free bypass. In yeast, mutation of
RAD18, which in this organism abrogates PCNA ubiqui-
tination (3), results in complete loss of translesion replica-
tion and a very substantial decrease in error-free bypass
(22). In contrast, neither loss of RAD18 nor mutation of
K164 of PCNA has any impact on the overall eﬃciency of
replication. Although pcnaK164R cells exhibit a decrease
in use of TLS, loss of PCNA ubiquitination does not
signiﬁcantly impact on the eﬃciency with which the
lesion-containing plasmids are replicated, nor does it
reduce the frequency of error-free outcomes. This suggests
that other pathways readily compensate for any role
played by this modiﬁcation in activating error-free
bypass in DT40. Further work is needed to investigate
the genetic requirements of error-free bypass in this
system.
Which polymerases are catalytically active in thebypass
of (6–4) photoproducts?
Our data suggest that Polz plays an absolutely central role
in TLS across the (6–4) photoproduct in vivo, even though
in vitro studies suggest that no one polymerase is able to
eﬃciently bypass this lesion on its own (2). Two possible
scenarios can be advanced to explain this paradox. In the
ﬁrst, the bypass of (6–4) photoproducts is a two-step pro-
cess with one polymerase inserting a base opposite the
30T and a second polymerase, Polz, extending from the
Figure 6. REV1 is required for avoiding frameshifts during TLS. (A) The outcome of TLS in the cell lines indicated. Sequences are classiﬁed
according to frameshifts (incorrect number of bases inserted opposite the lesion), with deletions shown as < 2,  2o r 1 (blue), the correct two-base
insertion as 0 (green), and an extra base as +1 (red). More than one extra base was never observed. The non-frameshifted sequences are further
classiﬁed, shown as a stacked column, as correct bypass (AA inserted, dark green) or incorrect bypass (light green). In case of pQTs (on the left), the
error-free sequences were removed from the analysis; n/a, not applicable. The pQTs samples from the xpa rev3 and rev1 pcnaK164R cell lines gave
almost exclusively error-free results, and therefore could not be plotted, indicated as ‘na’ (not applicable); nd, not done. (B) Aligned example
sequences from replicated pQTo constructs recovered from xpa rev1 cells. The diﬀerent types of frameshift are annotated on the left.
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of the complete bypass reaction in vivo, aided by the
presence of accessory factors absent from the in vitro
assays (35).
In support of the two polymerase model, in vitro both
PolZ and Poli (the product of the RAD30B locus) are
capable of incorporating the ﬁrst base opposite the 30T
of a T–T(6–4) photoproduct, PolZ preferring G and Poli
G or A (36,42). Although neither can extend, this is eﬃ-
ciently performed by Polz, which inserts the correct A
opposite the 50T. Consistent with these observations,
insertion of G opposite the 30T is observed in vivo in
yeast and in one reporter system was shown to be depen-
dent on PolZ (43). However, in a diﬀerent sequence con-
text the Lawrence group reported much less frequent
dGMP insertion at the 30T in their wild-type strain,
which although reduced by disruption of PolZ was not
eliminated (35). The work presented here reveals that, in
DT40, incorporation of G at the 30T is infrequent, the
most common base used being A. Further, disruption of
PolZ (the sole RAD30 homologue in chickens, which
appear to lack Poli) does not lead to any diminution in
eﬃciency of bypass in our assay nor to any signiﬁcant
change in the pattern of incorporation opposite either
base of the photoproduct. This suggests that PolZ does
not play a signiﬁcant role in bypass of a T–T(6–4) photo-
product in DT40.
Which other polymerases could catalyse incorporation
at the 30T? It could be achieved by the one of the replica-
tive polymerases, as seen in the bacterial polymerase reac-
tion shown in Figure 1E. Although, genetic evidence has
implicated the Pol32 subunit of DNA polymerase d in
TLS in yeast (44) and Pold has been shown to insert A
opposite a thymine glycol in vitro (45), ﬁrm evidence for
the replicative polymerases playing a role in catalysis at a
(6–4) photoproduct in vivo is lacking and indeed is intrin-
sically diﬃcult to obtain. Even if Pold did incorporate A at
opposite the 30T, it is not unlikely that, in vivo, this would
trigger the proofreading activity of the enzyme. Polk, the
vertebrate homologue of Escherichia coli DinB (POLIV),
is another member of the Y family of translesion poly-
merases, which we have not studied in this article as it
has limited in vitro ability to incorporate or extend oppo-
site a (6–4) photoproduct (46–49).
So could Polz in DT40 be catalysing the complete
bypass reaction in vivo as has been previously suggested
for yeast (35)? There is yet to be a formal biochemical
analysis of the polymerase activity of a vertebrate Polz
and somewhat conﬂicting in vitro results have been
reported for the ability of the yeast enzyme (yPolz)t o
Figure 7. The C-terminal domain of REV1 is required for its role in restraining Polz.( A) Replication eﬃciency of the pQTs and pQTo shuttle
plasmids assayed in wt cells and in rev1 mutant cells complemented with full length human REV1 (hREV1), a catalytically inactive point mutant
(hREV1
[D570AE571A]) and a C-terminal truncation starting at residue 1138 (hREV1
[1–1137]). The average and SEM of 3–5 experiments is shown.
(B) The proportion of TLS versus error-free bypass in pQTs sequences recovered from the indicated cell lines, shown as a percentage of the total.
(C) The outcome of TLS in pQTo in the cell lines indicated, classiﬁed according to frameshifts as in Figure 6.
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detectable bypass by yPolz (36,42), showing strong inhibi-
tion at the 30T, while another reported ineﬃcient bypass
when yPolz was used in a molar excess to the template
(50). Drosophila Polz, which resembles the yeast enzyme,
has also been found to be incapable of nucleotide incor-
poration opposite a (6–4) photoproduct (51). Despite its
reluctance to incorporate bases opposite lesions in vitro,
Polz has a remarkable ability to extend from a primer
terminus mismatched with a lesion-containing base,
which it extends almost as eﬃciently as on an undamaged
template (42,52). It is this latter property that has contrib-
uted signiﬁcantly to the notion of bypass being a two-step
process. However, these in vitro studies do not place Polz
in its physiological context with other potentially crucial
factors such as PCNA and RPA and the possibility
remains that in vivo Polz is capable of insertion at both
the 30 and 50T of the photoproduct, and of extension from
these inserted bases. We have shown here that loss of two
factors, REV1 and ubiquitinated PCNA, result in
decreased eﬃciency and accuracy of Polz-dependent TLS
and that, further, the phenotype of the rev1 pcnaK164R
doubly mutant cells is very similar to that of the rev3
mutant in terms of bypass, suggesting that either factor
can act independently through Polz. In the case of Polz,
this raises an interesting paradox since the only demon-
strated ubiquitin-binding activity associated with Polz is
indirectly via the UBM domains of REV1. Thus, the pre-
cise mechanism by which PCNA ubiquitination promotes
Polz-dependent translesion synthesis remains unclear.
Finally, it is noteworthy that nucleotide incorporation
preferences exhibited by Polz in the in vitro (6–4) photo-
product bypass experiments of Guo et al. (50), discussed
above, closely matches what we report here for in vivo
bypass. Thus, a number of rather indirect lines of evidence
point to Polz being the sole catalytic activity responsible
for bypass of this lesion in vivo. However, further work is
needed to formally distinguish whether bypass requires
one or two translesion polymerases.
The roles played by REV1during lesion bypass
REV1 possesses very limited catalytic activity against a
small number of lesions, such as abasic sites, and exhibits
no ability to bypass a photoproduct (53,54). Indeed, the
role of REV1 in bypass of UV damage tolerance is inde-
pendent of its catalytic function (19). The heart of this
non-catalytic function of REV1 resides in its C-terminus,
which likely acts as an adaptor between the replisome and
the incoming catalytic TLS polymerase (20,55). In the case
of the (6–4)T–T photoproduct, we show here that
the relevant polymerase coordinated by REV1 is Polz,
which interacts with REV1 via its non-catalytic REV7
subunit (7).
The dependence of Polz activity on REV1 in vivo in
budding yeast is well established. Early genetic data
demonstrated that REV3/7 were important for all induced
mutagenesis while the requirement for REV1 was some-
what dependent on the context, appearing important only
at base substitution but not frameshift alleles (56,57).
A potential explanation for this was provided by a study
from the Fuchs group that showed that REV1 was
required for bypass of a AAF adduct when the primer
terminus was at the lesion, but not when the template
slipped eﬀectively bypassing the lesion by deletion (58),
suggesting that REV1 was required for Polz to eﬃciently
extend from a mismatched terminus in vivo. The ability of
Polz to generate complex+1 frameshifts in yeast is also
dependent on REV1 (59). However, since this function of
Polz was entirely dependent on REV1, it was not possible
to distinguish between a potential role for REV1 in main-
taining accurate contact between Polz and the template
from simple failure to recruit Polz at all.
Since the recruitment of Polz in DT40 is only partially
dependent on REV1, we have been able to show the pre-
sence of REV1 also modiﬁes the catalytic behaviour of
Polz ensuring that it incorporates nucleotides in frame
with the damaged template. Two mechanisms could be
envisaged to account for this observation. The ﬁrst is
that REV1 is required to recruit an exonuclease that
trims excess nucleotides synthesized by Polz during
bypass. The second, which we favour, is that REV1 struc-
turally restrains Polz, forcing it to ‘count’ the number of
nucleotides it incorporates relative to the template. The
elucidation of the exact mechanism by which it does this
is unclear and will likely require formal structural studies
of the complexes formed by REV1 and Polz at the stalled
replisome. Interestingly, in this context, a recent study has
implicated REV1 in maintaining the stability of trinucleo-
tide repeats in S. cerevisiae that is independent of Polz (60)
suggesting that REV1 may play a role in avoidance of
aberrant secondary structure formation during general
replication. It will thus be interesting to determine the
extent to which these functions of REV1 are related and
how they apply to other lesions, DNA structures and
polymerases in both general and translesion replication.
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